Palisade Capital Management’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-6,500
| Closed | -$219K | – | 575 |
|
|
2016
Q2 | $219K | Buy |
6,500
+2,250
| +53% | +$75.8K | 0.01% | 514 |
|
|
2016
Q1 | $225K | Buy |
4,250
+1,250
| +42% | +$66.2K | 0.01% | 515 |
|
|
2015
Q4 | $230K | Sell |
3,000
-4,500
| -60% | -$345K | 0.01% | 511 |
|
|
2015
Q3 | $308K | Buy |
7,500
+2,000
| +36% | +$82.1K | 0.01% | 492 |
|
|
2015
Q2 | $389K | Buy |
5,500
+1,250
| +29% | +$88.4K | 0.01% | 485 |
|
|
2015
Q1 | $378K | Buy |
+4,250
| New | +$378K | 0.01% | 468 |
|